Astanor

Venture

Astanor look for scalable businesses that can have global impact.
We work closely both on the board and through our network of
industry experts to unlock opportunities and drive hyper growth.

Assets Under
Management: €800M

Investment
focus

– Target: Series A and B
– Ticket – €5-10M
– Europe + US

Portfolio companies

  • Source Ag

    Venture

    Feeding a healthier tomorrow with A.I. powered indoor agriculture.

  • Plantible

    Venture

    Plant-based nutrition for all humanity.

  • Calyxia

    Venture

    Ending global microplastic pollution with the power of green chemistry

  • Micro Harvest

    Venture

    A resilient food system, using the power of microorganisms

  • Monarch

    Venture

    Accelerating Regenerative Agriculture

  • Produce Pay

    Venture

    Empowering growers from seed to sale

  • Reshape

    Venture

    The most impactful microbiology lab automation robotics suite empowering the bio based economy

  • Standing Ovation

    Venture

    Animal-free caseins produced through precision fermentation to supply the Industry with low-impact proteins

Venture Investment Team

  • Valerie Christy

    Location: US

  • Eric Archambeau

    Location: Europe

  • Laetitia de Panafieu

    Location: Europe

  • Harry Briggs

    Location: Europe

  • Arnout Dijkhuizen

    Location: Europe

  • Arne Hautekiet

    Location: Europe

  • Pavlos Kalaitzoglou

    Location: Europe

  • George Powlick

    Location: US

  • Christina Ulardic

    Location: Europe

  • Hendrik Van Asbroeck

    Location: Europe

  • Marie Wennergren

    Location: Europe

Seed

We partner with visionary entrepreneurs at the earliest stages of development by providing seed funding. Thereafter we support, for example in formalizing governance, technical or commercial strategy.

Investment
focus

– Target: Pre-Seed, Seed
– Ticket: €1M
– Europe + US

Portfolio companies

  • Holobiome

    Seed

    Developing first-in-class therapies from the human microbiome.

  • Unlocked Labs

    Seed

    Next generation probiotics

Your interlocutor

Christina Ulardic

Partner

Ventures, Investment team